Edwards Lifesciences Corp. buy Wells Fargo & Company
Start price
02.02.24
/
50%
€77.44
Target price
02.02.25
€87.14
Performance (%)
-25.81%
Price
26.07.24
€57.45
Summary
This prediction is currently active. The prediction for Edwards Lifesciences Corp. disappoints with a performance of -25.81%. This prediction currently runs until 02.02.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Edwards Lifesciences Corp. | -30.113% | -30.113% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $94.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€56.76
25.07.24
25.07.24
€82.91
25.07.25
25.07.25
1.22%
26.07.24
26.07.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€80.16
26.04.24
26.04.24
€92.49
26.04.25
26.04.25
-28.33%
26.07.24
26.07.24